Structure-activity relationships in toll-like receptor 2-agonists leading to simplified monoacyl lipopeptides.
about
Targeting Toll-like receptors with small molecule agentsUltrashort cationic lipopeptides and lipopeptoids selectively induce cytokine production in macrophagesPosition and length of fatty acids strongly affect receptor selectivity pattern of human pancreatic polypeptide analogues.Human Toll-like receptor 8-selective agonistic activities in 1-alkyl-1H-benzimidazol-2-aminesDeterminants of activity at human Toll-like receptors 7 and 8: quantitative structure-activity relationship (QSAR) of diverse heterocyclic scaffolds.Structure-activity relationships in human Toll-like receptor 8-active 2,3-diamino-furo[2,3-c]pyridines.Lipoteichoic acid from Staphylococcus aureus induces lung endothelial cell barrier dysfunction: role of reactive oxygen and nitrogen speciesToll-like receptor-8 agonistic activities in C2, C4, and C8 modified thiazolo[4,5-c]quinolinesDesign and development of stable, water-soluble, human Toll-like receptor 2 specific monoacyl lipopeptides as candidate vaccine adjuvants.Novel toll-like receptor 2 ligands for targeted pancreatic cancer imaging and immunotherapy.TLR2 & Co: a critical analysis of the complex interactions between TLR2 and coreceptors.Immunostimulation by synthetic lipopeptide-based vaccine candidates: structure-activity relationships.Directing the immune system with chemical compounds.Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: potential clinical impact.Structure-activity relationships in human Toll-like receptor 2-specific monoacyl lipopeptides.Exquisite selectivity for human toll-like receptor 8 in substituted furo[2,3-c]quinolines.Peptide Lipidation - A Synthetic Strategy to Afford Peptide Based Therapeutics.
P2860
Q26992220-5F95AC33-EBBD-4E28-B733-4C7C426C7C3DQ28485935-10D09455-5753-4E97-AFD3-E3436B562F75Q33919544-D51805CC-4379-4A21-8C57-4FFF973CB7C5Q34164851-A0E3873B-4322-49A5-B984-9508213B8025Q34313816-5FAA1D03-6197-44ED-B3E2-75387058050EQ34394100-D142573A-5403-4E30-9DC7-68C719AC3050Q34482086-C278FCED-1D65-436A-995B-C12490162953Q36625137-BD1917B9-566E-4D6D-A2E3-095AA1668396Q37352073-E5D8F811-6192-4C13-90BE-574E70005CB6Q37389360-599B5D8C-28D6-4D38-A9A0-70FE617A2129Q38132733-B01D3797-749A-4F5C-8D62-AE8B401DDED2Q38153040-DC4DA3FC-C0E1-45CD-B131-2517B4AF01EBQ38201155-4931086C-9C6F-43F1-9C8F-7B6B12108C44Q38279548-AB5BFCD5-4688-48C5-9970-C7EC52D2EEF2Q42050375-00E012AC-4735-4A4B-8880-2D8673A113E6Q42096062-1A475ADA-94E1-4AF6-9110-5271477EA336Q47590580-90BDA56B-BF49-4C4E-B2E3-0D4C376F9B5B
P2860
Structure-activity relationships in toll-like receptor 2-agonists leading to simplified monoacyl lipopeptides.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Structure-activity relationshi ...... plified monoacyl lipopeptides.
@en
Structure-activity relationshi ...... plified monoacyl lipopeptides.
@nl
type
label
Structure-activity relationshi ...... plified monoacyl lipopeptides.
@en
Structure-activity relationshi ...... plified monoacyl lipopeptides.
@nl
prefLabel
Structure-activity relationshi ...... plified monoacyl lipopeptides.
@en
Structure-activity relationshi ...... plified monoacyl lipopeptides.
@nl
P2093
P2860
P356
P1476
Structure-activity relationshi ...... plified monoacyl lipopeptides.
@en
P2093
Breanna M Crall
Geetanjali Agnihotri
Hemamali J Warshakoon
Rajalakshmi Balakrishna
Subbalakshmi S Malladi
Sunil A David
Timothy P Day
Tyler C Lewis
P2860
P304
P356
10.1021/JM201071E
P407
P577
2011-11-04T00:00:00Z